首页 > 最新文献

Jcpsp-Journal of the College of Physicians and Surgeons Pakistan最新文献

英文 中文
Identification and Association of Polymorphism rs2073618 of the Osteoprotegerin Gene in Type 2 Diabetics with and without Retinopathy. 骨质保护素基因rs2073618多态性在伴有和不伴有视网膜病变的2型糖尿病患者中的鉴定及相关性。
IF 1 4区 医学 Q3 Medicine Pub Date : 2023-09-01 DOI: 10.29271/jcpsp.2023.09.959
Erum Tariq, Palvasha Waheed, Asifa Majeed, Amir Rashid
OBJECTIVE To identify and determine the association of SNP (rs2073618) of OPG gene in diabetics with and without retinopathy and in healthy controls. STUDY DESIGN Descriptive study. Place and Duration of the Study: Department of Biochemistry and Molecular Biology, Army Medical College, Rawalpindi in collaboration with Chemical Pathology Laboratory, Pak Emirates Military Hospital, Rawalpindi and Armed Forces Institute of Ophthalmology, Rawalpindi, from June 2021 to May 2022. METHODOLOGY Participants aged 25-70 years were inducted and divided into three equal groups. Group I consisted of diabetics with retinopathy (n = 50), group II was diabetics without retinopathy (n = 50), and group III was healthy individuals (n = 50). DNA was extracted and allele specific PCR technique was adopted using specifically designed primers. Results were analysed using the software Statistical Package for Social Sciences (SPSS) version 22.0 and online bio-informatics tool SNPstats. RESULTS CC, CG, and GG genotypes were found to be present in 94%, 4%, and 2% in diabetics without retinopathy, 92%, 4%, and 4% in diabetics with retinopathy, respectively, and 100% presence of CC genotype only in healthy controls. C and G alleles were present in 96% and 4%, respectively, in diabetics without retinopathy, with 100% presence of only C allele in healthy subjects. The genotypic assessment using the models showed no significant association. CONCLUSION SNP rs2073618 of OPG gene was identified in all study groups without any significant distribution or association with the development of diabetic retinopathy. The major genotype C/C was found in the majority of subjects in all groups. KEY WORDS Allele specific PCR, Diabetic retinopathy, Single nucleotide polymorphism, Type 2 Diabetes mellitus.
目的:鉴定和确定OPG基因SNP(rs2073618)在糖尿病合并和不合并视网膜病变患者及健康对照中的相关性。研究设计:描述性研究。研究地点和持续时间:2021年6月至2022年5月,拉瓦尔品第陆军医学院生物化学和分子生物学系与拉瓦尔品迪巴基斯坦阿联酋军事医院化学病理学实验室和拉瓦尔品第武装部队眼科研究所合作。方法:将25-70岁的参与者纳入研究,并分为三组。第一组由患有视网膜病变的糖尿病患者(n=50)组成,第二组为没有视网膜病变的患者(n=5 0),第三组为健康人(n=5)。提取DNA,并采用等位基因特异性PCR技术,使用专门设计的引物。使用社会科学统计软件包(SPSS)22.0版和在线生物信息学工具SNPstats对结果进行分析。结果:CC、CG和GG基因型在无视网膜病变的糖尿病患者中分别存在94%、4%和2%,在有视网膜病变的患者中分别存在92%、4%和4%,并且只有健康对照中存在100%的CC基因型。在没有视网膜病变的糖尿病患者中,C和G等位基因分别存在96%和4%,而在健康受试者中,只有100%的C等位基因存在。使用模型进行的基因型评估没有显示出显著的相关性。结论:OPG基因的SNP rs2073618在所有研究组中均被鉴定,与糖尿病视网膜病变的发生没有任何显著的分布或关联。在所有组的大多数受试者中都发现了主要的C/C基因型。关键词:等位基因特异性聚合酶链式反应,糖尿病视网膜病变,单核苷酸多态性,2型糖尿病。
{"title":"Identification and Association of Polymorphism rs2073618 of the <em>Osteoprotegerin </em>Gene in Type 2 Diabetics with and without Retinopathy.","authors":"Erum Tariq,&nbsp;Palvasha Waheed,&nbsp;Asifa Majeed,&nbsp;Amir Rashid","doi":"10.29271/jcpsp.2023.09.959","DOIUrl":"10.29271/jcpsp.2023.09.959","url":null,"abstract":"OBJECTIVE To identify and determine the association of SNP (rs2073618) of OPG gene in diabetics with and without retinopathy and in healthy controls. STUDY DESIGN Descriptive study. Place and Duration of the Study: Department of Biochemistry and Molecular Biology, Army Medical College, Rawalpindi in collaboration with Chemical Pathology Laboratory, Pak Emirates Military Hospital, Rawalpindi and Armed Forces Institute of Ophthalmology, Rawalpindi, from June 2021 to May 2022. METHODOLOGY Participants aged 25-70 years were inducted and divided into three equal groups. Group I consisted of diabetics with retinopathy (n = 50), group II was diabetics without retinopathy (n = 50), and group III was healthy individuals (n = 50). DNA was extracted and allele specific PCR technique was adopted using specifically designed primers. Results were analysed using the software Statistical Package for Social Sciences (SPSS) version 22.0 and online bio-informatics tool SNPstats. RESULTS CC, CG, and GG genotypes were found to be present in 94%, 4%, and 2% in diabetics without retinopathy, 92%, 4%, and 4% in diabetics with retinopathy, respectively, and 100% presence of CC genotype only in healthy controls. C and G alleles were present in 96% and 4%, respectively, in diabetics without retinopathy, with 100% presence of only C allele in healthy subjects. The genotypic assessment using the models showed no significant association. CONCLUSION SNP rs2073618 of OPG gene was identified in all study groups without any significant distribution or association with the development of diabetic retinopathy. The major genotype C/C was found in the majority of subjects in all groups. KEY WORDS Allele specific PCR, Diabetic retinopathy, Single nucleotide polymorphism, Type 2 Diabetes mellitus.","PeriodicalId":54905,"journal":{"name":"Jcpsp-Journal of the College of Physicians and Surgeons Pakistan","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10578818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Bolus/Basal Insulin Ratio on HbA1c and Lipid Profile in Adult Patients with Type 1 Diabetes Mellitus. 大剂量/基础胰岛素比对成年1型糖尿病患者HbA1c和血脂的影响
IF 1 4区 医学 Q3 Medicine Pub Date : 2023-09-01 DOI: 10.29271/jcpsp.2023.09.990
Murat Calapkulu, Muhammed Erkam Sencar, Ilknur Ozturk Unsal, Davut Sakiz, Mustafa Ozbek, Erman Cakal

Objective: To evaluate the existence of any relationship between the bolus/basal (B/b) insulin ratio and HbA1c and lipid profile in patients with Type 1 Diabetes mellitus (T1DM) on a basal-bolus treatment regimen.

Study design: Retrospective observational study. Place and Duration of the Study: University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey, from January 2015 to March 2020.

Methodology: This retrospective-observational study included 181 adult patients with T1DM. They were divided into two groups with <1.5 and ≥1.5 B/b insulin ratios, and the parameters were compared.

Results: The subjects comprised 94 females and 87 males with a mean age of 30.1 ± 9.2 years. Microvascular complications and dyslipidaemia were found in 30.9% and 68.5% of the patients, respectively. B/b insulin ratio of ≥1.5 was observed in 65.1% of the patients. The HbA1c level was <58 mmol/mol in 11.6% of the patients. A positive correlation was found between the B/b insulin ratio and HbA1c level. Fasting Plasma Glucose (FPG) and HbA1c levels were higher in those with ≥1.5 B/b insulin ratio. The rate of patients who reached the optimal HbA1c level was 3.57-fold lower in those with ≥1.5 B/b ratio.

Conclusion: A higher B/b insulin ratio was associated with higher HbA1c levels in patients with T1DM treated with intensive insulin therapy. Prospective studies are needed to define a causal relationship between the B/b insulin ratio, glycaemic parameters, and lipid profile.

Key words: Bolus/basal insulin ratio, Type 1 Diabetes mellitus, HbA1c, Low-density lipoprotein, Lipid profile.

目的:评价1型糖尿病(T1DM)患者在基础-灌注治疗方案中,B/ B胰岛素比与HbA1c和血脂之间的关系。研究设计:回顾性观察性研究。研究地点和时间:2015年1月至2020年3月,土耳其安卡拉Diskapi Yildirim Beyazit培训和研究医院健康科学大学。方法:这项回顾性观察性研究纳入了181例成年T1DM患者。结果:女性94例,男性87例,平均年龄30.1±9.2岁。微血管并发症和血脂异常发生率分别为30.9%和68.5%。65.1%的患者B/ B胰岛素比值≥1.5。结论:胰岛素强化治疗的T1DM患者,较高的B/ B胰岛素比值与较高的HbA1c水平相关。需要前瞻性研究来确定B/ B胰岛素比、血糖参数和血脂之间的因果关系。关键词:胰岛素/基础比,1型糖尿病,糖化血红蛋白,低密度脂蛋白,脂质谱
{"title":"Impact of Bolus/Basal Insulin Ratio on HbA1c and Lipid Profile in Adult Patients with Type 1 Diabetes Mellitus.","authors":"Murat Calapkulu,&nbsp;Muhammed Erkam Sencar,&nbsp;Ilknur Ozturk Unsal,&nbsp;Davut Sakiz,&nbsp;Mustafa Ozbek,&nbsp;Erman Cakal","doi":"10.29271/jcpsp.2023.09.990","DOIUrl":"https://doi.org/10.29271/jcpsp.2023.09.990","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the existence of any relationship between the bolus/basal (B/b) insulin ratio and HbA1c and lipid profile in patients with Type 1 Diabetes mellitus (T1DM) on a basal-bolus treatment regimen.</p><p><strong>Study design: </strong>Retrospective observational study. Place and Duration of the Study: University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey, from January 2015 to March 2020.</p><p><strong>Methodology: </strong>This retrospective-observational study included 181 adult patients with T1DM. They were divided into two groups with <1.5 and ≥1.5 B/b insulin ratios, and the parameters were compared.</p><p><strong>Results: </strong>The subjects comprised 94 females and 87 males with a mean age of 30.1 ± 9.2 years. Microvascular complications and dyslipidaemia were found in 30.9% and 68.5% of the patients, respectively. B/b insulin ratio of ≥1.5 was observed in 65.1% of the patients. The HbA1c level was <58 mmol/mol in 11.6% of the patients. A positive correlation was found between the B/b insulin ratio and HbA1c level. Fasting Plasma Glucose (FPG) and HbA1c levels were higher in those with ≥1.5 B/b insulin ratio. The rate of patients who reached the optimal HbA1c level was 3.57-fold lower in those with ≥1.5 B/b ratio.</p><p><strong>Conclusion: </strong>A higher B/b insulin ratio was associated with higher HbA1c levels in patients with T1DM treated with intensive insulin therapy. Prospective studies are needed to define a causal relationship between the B/b insulin ratio, glycaemic parameters, and lipid profile.</p><p><strong>Key words: </strong>Bolus/basal insulin ratio, Type 1 Diabetes mellitus, HbA1c, Low-density lipoprotein, Lipid profile.</p>","PeriodicalId":54905,"journal":{"name":"Jcpsp-Journal of the College of Physicians and Surgeons Pakistan","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10578822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and Safety of Combined Chemotherapy Regimens with Bevacizumab in Platinum-sensitive Ovarian Cancers. 贝伐单抗联合化疗方案治疗铂敏感性卵巢癌的疗效和安全性。
IF 1 4区 医学 Q3 Medicine Pub Date : 2023-09-01 DOI: 10.29271/jcpsp.2023.09.1006
Fatih Tay, Mustafa Buyukkor, Ozturk Ates

Objective: To determine the differences in terms of overall survival in platinum-sensitive ovarian cancer (PSOC) patients undergoing various chemotherapy protocols, and to demonstrate patient tolerance, toxicity, and efficacy data with the use of bevacizumab in different protocols.

Study design: An observational study. Place and Duration of the Study: Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey, from January 2018 to January 2022.

Methodology:  Patients aged 18 and above, who had received treatment for PSOC, were included in the study. Patients with platinum-resistant disease and those for whom bevacizumab usage was contraindicated were not enrolled in the study.

Results: For the 95 patients, the median age was 55 (34-78) years. Median follow-up are 39.7 (39.2-47.5) months. Median progression-free survival (PFS) of the patients are 10.8 (7.3-14.0) months for carboplatin-gemcitabine-bevacizumab (CGB), 10.9 (IQR 5.5-14.3) months in the carboplatin-liposomal doxorubicin-bevacizumab (CLdB) arms, and 6.1 (IQR 5.8-14.3) months in the carboplatin-paclitaxel-bevacizumab (CPB) group (p=0.79). The median overall survivals (OS) are 37.9 (IQR 33.3-46.9) months in the CGB arm, 41.0 (IQR 38.0-50.3) months CPB arm, and 41.3 (IQR 38.1-52.3) months in the CLdB arm (p=0.173).

Conclusion: There was no difference in terms of overall survival among all three chemotherapy protocols. However, due to the difference in toxicity, the treatment should be selected on a patient-specific basis. Additionally, the use of bevacizumab at a dose of 7.5 mg/kg was demonstrated to be equivalent to using 15 mg/kg in terms of overall survival. This lower dose is also important to avoid financial toxicity.

Key words: Bevacizumab, Ovarian cancer, Platinum-based chemotherapy, Tolerability, Adverse clinical events.

目的:确定铂敏感性卵巢癌(PSOC)患者接受不同化疗方案的总生存期差异,并展示不同方案中使用贝伐单抗的患者耐受性、毒性和疗效数据。研究设计:观察性研究。研究地点和时间:Abdurrahman Yurtaslan博士,土耳其安卡拉肿瘤培训和研究医院,2018年1月至2022年1月。方法:18岁及以上接受过PSOC治疗的患者纳入研究。铂耐药疾病患者和贝伐单抗禁忌症患者未纳入研究。结果:95例患者中位年龄为55(34 ~ 78)岁。中位随访时间为39.7(39.2-47.5)个月。卡铂-吉西他滨-贝伐单抗(CGB)组患者的中位无进展生存期(PFS)为10.8(7.3-14.0)个月,卡铂-脂质体阿霉素-贝伐单抗(CLdB)组患者的中位无进展生存期(PFS)为10.9 (IQR 5.5-14.3)个月,卡铂-紫杉醇-贝伐单抗(CPB)组患者的中位PFS为6.1 (IQR 5.8-14.3)个月(p=0.79)。CGB组的中位总生存期(OS)为37.9 (IQR为33.3-46.9)个月,CPB组为41.0 (IQR为38.0-50.3)个月,CLdB组为41.3 (IQR为38.1-52.3)个月(p=0.173)。结论:三种化疗方案在总生存率方面没有差异。然而,由于毒性的差异,治疗应根据患者的具体情况进行选择。此外,在总生存期方面,使用7.5 mg/kg剂量的贝伐单抗被证明与使用15 mg/kg剂量相当。这种较低的剂量对于避免经济毒性也很重要。关键词:贝伐单抗,卵巢癌,铂基化疗,耐受性,临床不良事件
{"title":"Efficacy and Safety of Combined Chemotherapy Regimens with Bevacizumab in Platinum-sensitive Ovarian Cancers.","authors":"Fatih Tay,&nbsp;Mustafa Buyukkor,&nbsp;Ozturk Ates","doi":"10.29271/jcpsp.2023.09.1006","DOIUrl":"https://doi.org/10.29271/jcpsp.2023.09.1006","url":null,"abstract":"<p><strong>Objective: </strong>To determine the differences in terms of overall survival in platinum-sensitive ovarian cancer (PSOC) patients undergoing various chemotherapy protocols, and to demonstrate patient tolerance, toxicity, and efficacy data with the use of bevacizumab in different protocols.</p><p><strong>Study design: </strong>An observational study. Place and Duration of the Study: Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey, from January 2018 to January 2022.</p><p><strong>Methodology: </strong> Patients aged 18 and above, who had received treatment for PSOC, were included in the study. Patients with platinum-resistant disease and those for whom bevacizumab usage was contraindicated were not enrolled in the study.</p><p><strong>Results: </strong>For the 95 patients, the median age was 55 (34-78) years. Median follow-up are 39.7 (39.2-47.5) months. Median progression-free survival (PFS) of the patients are 10.8 (7.3-14.0) months for carboplatin-gemcitabine-bevacizumab (CGB), 10.9 (IQR 5.5-14.3) months in the carboplatin-liposomal doxorubicin-bevacizumab (CLdB) arms, and 6.1 (IQR 5.8-14.3) months in the carboplatin-paclitaxel-bevacizumab (CPB) group (p=0.79). The median overall survivals (OS) are 37.9 (IQR 33.3-46.9) months in the CGB arm, 41.0 (IQR 38.0-50.3) months CPB arm, and 41.3 (IQR 38.1-52.3) months in the CLdB arm (p=0.173).</p><p><strong>Conclusion: </strong>There was no difference in terms of overall survival among all three chemotherapy protocols. However, due to the difference in toxicity, the treatment should be selected on a patient-specific basis. Additionally, the use of bevacizumab at a dose of 7.5 mg/kg was demonstrated to be equivalent to using 15 mg/kg in terms of overall survival. This lower dose is also important to avoid financial toxicity.</p><p><strong>Key words: </strong>Bevacizumab, Ovarian cancer, Platinum-based chemotherapy, Tolerability, Adverse clinical events.</p>","PeriodicalId":54905,"journal":{"name":"Jcpsp-Journal of the College of Physicians and Surgeons Pakistan","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10563471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Oxidant and Antioxidant Status in the Aqueous Humour of Cataract Patients with and without Type 2 Diabetes Mellitus. 合并和不合并2型糖尿病白内障患者房水中氧化剂和抗氧化状态的比较。
IF 1 4区 医学 Q3 Medicine Pub Date : 2023-09-01 DOI: 10.29271/jcpsp.2023.09.1019
Shoaib Bin Aleem, Amber Farooq, Teyyeb Azeem Janjua

Objectives: To compare the total oxidant status (TOS), total antioxidant capacity (TAC), and oxidative stress index (OSI) in the aqueous humour of cataract patients with and without type 2 diabetes mellitus (T2DM).

Study design: Cross-sectional analytical study. Place and Duration of the Study: Department of Physiology, Army Medical College, National University of Medical Sciences, Rawalpindi, Pakistan in collaboration with Armed Forces Institute of Ophthalmology, from 1st June 2022 to 31st January 2023.

Methodology: A total of 120 individuals were recruited and divided into 2 equal groups. Sample of aqueous humour was collected, and the total oxidant status, and total antioxidant status were measured by spectrophotometry. Blood samples were collected to measure the fasting glucose and glycosylated haemoglobin levels. Results were analysed by SPSS version 24 and p-value ≤0.05 was considered significant.

Results: Total oxidative stress and OSI were (55.57±5.46) vs. (33.75±4.28) = p (0.001), (32.79±9.23) vs. (13.28±3.02) = p (0.001) found significantly increased in aqueous humour of diabetic patients while TAC was reduced (1.86±0.41) vs. (2.62 ± 0.45) = p (0.001) compared to the non-diabetics. Fasting blood glucose (109.18±12.32 vs. 91.61±5.71 mg/dl, p=0.001) and glycosylated haemoglobin levels (6.46±0.85 vs.5.43±0.85, p=0.001) were also found significantly high in the diabetic group compared to the non-diabetics.

Conclusion: Increased levels of glucose and glycosylated haemoglobin increase oxidative stress in the blood of T2DM patients. This raises the total oxidative stress in the aqueous homor while lowering the TAC. This disturbed oxidant-antioxidant status in the aqueous humour of diabetic patients plays an important role in the development of cataract in T2DM patients compared to non-diabetics.

Key words: Cataract, Aqueous humour, Oxidative stress, Type 2 diabetes mellitus.

目的:比较合并和不合并2型糖尿病(T2DM)的白内障患者房水的总氧化状态(TOS)、总抗氧化能力(TAC)和氧化应激指数(OSI)。研究设计:横断面分析研究。研究地点和时间:巴基斯坦拉瓦尔品第国立医科大学陆军医学院生理学系与武装部队眼科研究所合作,研究时间为2022年6月1日至2023年1月31日。方法:共招募120人,分为两组。采集幽默水样品,用分光光度法测定其总氧化状态和总抗氧化状态。采集血样测量空腹血糖和糖化血红蛋白水平。结果采用SPSS version 24进行分析,p值≤0.05为差异有统计学意义。结果:总氧化应激和OSI分别为(55.57±5.46)比(33.75±4.28)= p(0.001),(32.79±9.23)比(13.28±3.02)= p(0.001),与非糖尿病患者相比,糖尿病患者房水中总氧化应激和OSI显著升高(1.86±0.41)比(2.62±0.45)= p(0.001)。糖尿病组空腹血糖(109.18±12.32 vs. 91.61±5.71 mg/dl, p=0.001)和糖化血红蛋白水平(6.46±0.85 vs.5.43±0.85,p=0.001)也明显高于非糖尿病组。结论:血糖和糖化血红蛋白水平升高会增加T2DM患者血液中的氧化应激。这增加了水溶液中的总氧化应激,同时降低了TAC。与非糖尿病患者相比,糖尿病患者房水中这种紊乱的氧化-抗氧化状态在T2DM患者白内障的发展中起着重要作用。关键词:白内障,房水,氧化应激,2型糖尿病
{"title":"Comparison of Oxidant and Antioxidant Status in the Aqueous Humour of Cataract Patients with and without Type 2 Diabetes Mellitus.","authors":"Shoaib Bin Aleem,&nbsp;Amber Farooq,&nbsp;Teyyeb Azeem Janjua","doi":"10.29271/jcpsp.2023.09.1019","DOIUrl":"https://doi.org/10.29271/jcpsp.2023.09.1019","url":null,"abstract":"<p><strong>Objectives: </strong>To compare the total oxidant status (TOS), total antioxidant capacity (TAC), and oxidative stress index (OSI) in the aqueous humour of cataract patients with and without type 2 diabetes mellitus (T2DM).</p><p><strong>Study design: </strong>Cross-sectional analytical study. Place and Duration of the Study: Department of Physiology, Army Medical College, National University of Medical Sciences, Rawalpindi, Pakistan in collaboration with Armed Forces Institute of Ophthalmology, from 1st June 2022 to 31st January 2023.</p><p><strong>Methodology: </strong>A total of 120 individuals were recruited and divided into 2 equal groups. Sample of aqueous humour was collected, and the total oxidant status, and total antioxidant status were measured by spectrophotometry. Blood samples were collected to measure the fasting glucose and glycosylated haemoglobin levels. Results were analysed by SPSS version 24 and p-value ≤0.05 was considered significant.</p><p><strong>Results: </strong>Total oxidative stress and OSI were (55.57±5.46) vs. (33.75±4.28) = p (0.001), (32.79±9.23) vs. (13.28±3.02) = p (0.001) found significantly increased in aqueous humour of diabetic patients while TAC was reduced (1.86±0.41) vs. (2.62 ± 0.45) = p (0.001) compared to the non-diabetics. Fasting blood glucose (109.18±12.32 vs. 91.61±5.71 mg/dl, p=0.001) and glycosylated haemoglobin levels (6.46±0.85 vs.5.43±0.85, p=0.001) were also found significantly high in the diabetic group compared to the non-diabetics.</p><p><strong>Conclusion: </strong>Increased levels of glucose and glycosylated haemoglobin increase oxidative stress in the blood of T2DM patients. This raises the total oxidative stress in the aqueous homor while lowering the TAC. This disturbed oxidant-antioxidant status in the aqueous humour of diabetic patients plays an important role in the development of cataract in T2DM patients compared to non-diabetics.</p><p><strong>Key words: </strong>Cataract, Aqueous humour, Oxidative stress, Type 2 diabetes mellitus.</p>","PeriodicalId":54905,"journal":{"name":"Jcpsp-Journal of the College of Physicians and Surgeons Pakistan","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10563474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ethanol-Associated Prolonged Immobilisation as a Cause of Rhabdomyolysis. 乙醇相关的长时间固定是横纹肌溶解的原因。
IF 1 4区 医学 Q3 Medicine Pub Date : 2023-09-01 DOI: 10.29271/jcpsp.2023.09.1084
Serdar Ozdemir, Abuzer Ozkan

Null.

Null。
{"title":"Ethanol-Associated Prolonged Immobilisation as a Cause of Rhabdomyolysis.","authors":"Serdar Ozdemir,&nbsp;Abuzer Ozkan","doi":"10.29271/jcpsp.2023.09.1084","DOIUrl":"https://doi.org/10.29271/jcpsp.2023.09.1084","url":null,"abstract":"<p><p>Null.</p>","PeriodicalId":54905,"journal":{"name":"Jcpsp-Journal of the College of Physicians and Surgeons Pakistan","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10563483","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Changes in Corneal Biomechanical Properties after Laser-Assisted in situ Keratomileusis and Photorefractive Keratectomy in Myopia. 激光辅助原位角膜磨砂术和屈光性角膜切除术后角膜生物力学特性的变化。
IF 1 4区 医学 Q3 Medicine Pub Date : 2023-09-01 DOI: 10.29271/jcpsp.2023.09.1023
Sadia Humayun, Yumna Waheed Bangash, Mazhar Ishaq, Habiba Yasmeen

Objective: To compare changes in corneal biomechanical properties after laser-assisted in situ keratomileusis (LASIK) and photorefractive keratectomy (PRK) in low and moderate myopia by Ocular Response Analyzer.

Study design: Quasi-experimental study. Place and Duration of the Study: Armed Forces Institute of Ophthalmology (AFIO), Rawalpindi, Pakistan, between September 2020 and April 2022.

Methodology: Myopic correction was done in forty-six eyes of twenty-three patients by PRK, and forty-seven eyes of twenty-four patients by LASIK. Corneal hysteresis (CH) and corneal resistance factor (CRF) were measured using Ocular Response Analyzer (ORA), pre-operatively, and then 1, 3, and 6 months, postoperatively. The relationship between the amount of myopia treated and biomechanical properties was also studied.

Results: CRF and CH were decreased significantly after LASIK and PRK. A significantly larger decrease in CRF was observed after LASIK as compared to PRK at 6 months (Mann-Whitney U test: CRF, p = 0.02); however, decrease in CH was not statistically significant between LASIK and PRK at 6 months period (Mann-Whitney U test: CH, p = 0.388). A significant correlation was observed between the changes in biomechanical properties and extent of myopic correction after LASIK and PRK.

Conclusion: Biomechanical strength of the cornea was significantly reduced by PRK and LASIK, which was also dependent on the spherical equivalent (SEQ) of myopic correction. A significantly larger change in CRF was observed after LASIK as compared to post PRK.

Key words: Myopia, Laser in situ keratomileusis, Photorefractive keratectomy, Cornea, Biomechanics.

目的:用眼反应分析仪比较低、中度近视患者激光原位角膜磨除术(LASIK)与光屈光性角膜切除术(PRK)术后角膜生物力学特性的变化。研究设计:准实验研究。研究地点和时间:2020年9月至2022年4月,巴基斯坦拉瓦尔品第武装部队眼科研究所(AFIO)。方法:23例患者46眼PRK矫正近视,24例患者47眼LASIK矫正近视。术前、术后1、3、6个月分别用眼反应分析仪(ORA)测定角膜迟滞(CH)和角膜阻力因子(CRF)。研究了近视度数与生物力学性能的关系。结果:LASIK和PRK术后CRF和CH均明显降低。6个月时,与PRK相比,LASIK术后CRF的下降幅度更大(Mann-Whitney U检验:CRF, p = 0.02);而6个月时,LASIK与PRK的CH降低无统计学意义(Mann-Whitney U检验:CH, p = 0.388)。观察到LASIK和PRK术后生物力学性能的变化与近视矫正程度有显著的相关性。结论:PRK和LASIK均显著降低了角膜的生物力学强度,并依赖于近视矫正的球形当量(SEQ)。与PRK后相比,LASIK术后观察到的CRF变化明显更大。关键词:近视,激光原位角膜磨镶术,光屈光性角膜切除术,角膜,生物力学
{"title":"Changes in Corneal Biomechanical Properties after Laser-Assisted <em>in situ</em> Keratomileusis and Photorefractive Keratectomy in Myopia.","authors":"Sadia Humayun,&nbsp;Yumna Waheed Bangash,&nbsp;Mazhar Ishaq,&nbsp;Habiba Yasmeen","doi":"10.29271/jcpsp.2023.09.1023","DOIUrl":"https://doi.org/10.29271/jcpsp.2023.09.1023","url":null,"abstract":"<p><strong>Objective: </strong>To compare changes in corneal biomechanical properties after laser-assisted in situ keratomileusis (LASIK) and photorefractive keratectomy (PRK) in low and moderate myopia by Ocular Response Analyzer.</p><p><strong>Study design: </strong>Quasi-experimental study. Place and Duration of the Study: Armed Forces Institute of Ophthalmology (AFIO), Rawalpindi, Pakistan, between September 2020 and April 2022.</p><p><strong>Methodology: </strong>Myopic correction was done in forty-six eyes of twenty-three patients by PRK, and forty-seven eyes of twenty-four patients by LASIK. Corneal hysteresis (CH) and corneal resistance factor (CRF) were measured using Ocular Response Analyzer (ORA), pre-operatively, and then 1, 3, and 6 months, postoperatively. The relationship between the amount of myopia treated and biomechanical properties was also studied.</p><p><strong>Results: </strong>CRF and CH were decreased significantly after LASIK and PRK. A significantly larger decrease in CRF was observed after LASIK as compared to PRK at 6 months (Mann-Whitney U test: CRF, p = 0.02); however, decrease in CH was not statistically significant between LASIK and PRK at 6 months period (Mann-Whitney U test: CH, p = 0.388). A significant correlation was observed between the changes in biomechanical properties and extent of myopic correction after LASIK and PRK.</p><p><strong>Conclusion: </strong>Biomechanical strength of the cornea was significantly reduced by PRK and LASIK, which was also dependent on the spherical equivalent (SEQ) of myopic correction. A significantly larger change in CRF was observed after LASIK as compared to post PRK.</p><p><strong>Key words: </strong>Myopia, Laser in situ keratomileusis, Photorefractive keratectomy, Cornea, Biomechanics.</p>","PeriodicalId":54905,"journal":{"name":"Jcpsp-Journal of the College of Physicians and Surgeons Pakistan","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10266777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cervical Mediastinoscopy as a Diagnostic Tool for Mediastinal Lymphadenopathy. 颈纵隔镜作为纵隔淋巴结病的诊断工具。
IF 1 4区 医学 Q3 Medicine Pub Date : 2023-09-01 DOI: 10.29271/jcpsp.2023.09.1062
Farhan Ahmad Majeed, Kamran Raheem, Usama Zafar, Sohail Saqib Chatha, Ahmad Raza, Arshman Rauf

Objective: To determine the yield of cervical mediastinoscopy in determining causes of mediastinal lymph node enlargement.

Study design: Observational study. Place and Duration of the Study: CMH Rawalpindi, Lahore and Multan, from January 2010 to December 2021.

Methodology: Patients who underwent lymph node biopsy through cervical mediastinoscopy approach were included. Record of the patients including age, gender, clinical presentation, and findings on CT scan chest were noted along with the record of preoperative complications and duration of surgery. Histopathology report was also recorded.

Results: Out of 398 patients, 259 (65%) were males and 139 (35%) were females. Out of 338 patients who were operated for diagnostic purpose, 157 (46%) had tuberculosis and 34 (10.1%) had sarcoidosis. Fifty-two (15.3%) were diagnosed to have malignancy including non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), and metastatic carcinoma of unspecified origin. Amongst staging group (n=60), 33 (55%) patients had negative mediastinal disease. Complication rate was 3.8%, including hoarseness of voice in three patients while 2 patients had wound infection requiring intervention.

Conclusion: Cervical mediastinoscopy is a safe and efficacious means of diagnosis in indeterminate mediastinal lymphadenopathy and staging of lung malignancy.

Key words: Mediastinoscopy, Lymph nodes, Tuberculosis, Lung cancer, Staging.

目的:探讨颈纵隔镜检查在诊断纵隔淋巴结肿大原因中的应用价值。研究设计:观察性研究。研究地点和时间:2010年1月至2021年12月,拉瓦尔品第、拉合尔和木尔坦的CMH。方法:纳入经颈纵隔镜入路行淋巴结活检的患者。记录患者的年龄、性别、临床表现、胸部CT扫描结果,并记录术前并发症和手术时间。同时记录组织病理学报告。结果:398例患者中,男性259例(65%),女性139例(35%)。在为诊断目的进行手术的338例患者中,157例(46%)患有结核病,34例(10.1%)患有结节病。52例(15.3%)被诊断为恶性肿瘤,包括非小细胞肺癌(NSCLC)、小细胞肺癌(SCLC)和来源不明的转移性癌。在分期组(n=60)中,33例(55%)患者的纵隔疾病呈阴性。并发症发生率为3.8%,其中嗓音嘶哑3例,伤口感染2例,需干预。结论:宫颈纵隔镜检查对不确定的纵隔淋巴结病及肺恶性肿瘤分期是一种安全有效的诊断手段。关键词:纵隔镜检查,淋巴结,结核,肺癌,分期
{"title":"Cervical Mediastinoscopy as a Diagnostic Tool for Mediastinal Lymphadenopathy.","authors":"Farhan Ahmad Majeed,&nbsp;Kamran Raheem,&nbsp;Usama Zafar,&nbsp;Sohail Saqib Chatha,&nbsp;Ahmad Raza,&nbsp;Arshman Rauf","doi":"10.29271/jcpsp.2023.09.1062","DOIUrl":"https://doi.org/10.29271/jcpsp.2023.09.1062","url":null,"abstract":"<p><strong>Objective: </strong>To determine the yield of cervical mediastinoscopy in determining causes of mediastinal lymph node enlargement.</p><p><strong>Study design: </strong>Observational study. Place and Duration of the Study: CMH Rawalpindi, Lahore and Multan, from January 2010 to December 2021.</p><p><strong>Methodology: </strong>Patients who underwent lymph node biopsy through cervical mediastinoscopy approach were included. Record of the patients including age, gender, clinical presentation, and findings on CT scan chest were noted along with the record of preoperative complications and duration of surgery. Histopathology report was also recorded.</p><p><strong>Results: </strong>Out of 398 patients, 259 (65%) were males and 139 (35%) were females. Out of 338 patients who were operated for diagnostic purpose, 157 (46%) had tuberculosis and 34 (10.1%) had sarcoidosis. Fifty-two (15.3%) were diagnosed to have malignancy including non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), and metastatic carcinoma of unspecified origin. Amongst staging group (n=60), 33 (55%) patients had negative mediastinal disease. Complication rate was 3.8%, including hoarseness of voice in three patients while 2 patients had wound infection requiring intervention.</p><p><strong>Conclusion: </strong>Cervical mediastinoscopy is a safe and efficacious means of diagnosis in indeterminate mediastinal lymphadenopathy and staging of lung malignancy.</p><p><strong>Key words: </strong>Mediastinoscopy, Lymph nodes, Tuberculosis, Lung cancer, Staging.</p>","PeriodicalId":54905,"journal":{"name":"Jcpsp-Journal of the College of Physicians and Surgeons Pakistan","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10266780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cancer Staging in Patients with Compromised Renal Function: Is PET/CT an Alternative to Contrast CT Scan? 肾功能受损患者的癌症分期:PET/CT是对比CT扫描的替代选择吗?
IF 1 4区 医学 Q3 Medicine Pub Date : 2023-09-01 DOI: 10.29271/jcpsp.2023.09.1076
Haider Ali, Syed Rashid Ul Amin, Abdul Hai

Null.

Null。
{"title":"Cancer Staging in Patients with Compromised Renal Function: Is PET/CT an Alternative to Contrast CT Scan?","authors":"Haider Ali,&nbsp;Syed Rashid Ul Amin,&nbsp;Abdul Hai","doi":"10.29271/jcpsp.2023.09.1076","DOIUrl":"https://doi.org/10.29271/jcpsp.2023.09.1076","url":null,"abstract":"<p><p>Null.</p>","PeriodicalId":54905,"journal":{"name":"Jcpsp-Journal of the College of Physicians and Surgeons Pakistan","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10563478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Rapid Antigen Detection Test with Reverse Transcription Polymerase Chain Reaction in Highly Suspected COVID-19 Patients. 快速抗原检测与逆转录聚合酶链反应在COVID-19高度疑似患者中的比较
IF 1 4区 医学 Q3 Medicine Pub Date : 2023-09-01 DOI: 10.29271/jcpsp.2023.09.1058
Muhammad Abdur Rahman Afridi, Zafar Ali, Naveed Iqbal

Objective: To compare Rapid Antigen Test (RAT) with Reverse Transcription Polymerase Chain Reaction (RT-PCR) in highly suspected COVID-19 patients and to determine its diagnostic parameters.

Study design: Hospital-based, descriptive/observational study. Place and Duration of the Study: Department of Medicine/COVID Complex, Medical Teaching Institution/Lady Reading Hospital, Peshawar, Khyber Pakhtunkhwa, Pakistan, from October 2021 to April 2022.

Methodology: A total of 300 highly suspected cases of COVID-19 of either gender admitted in the COVID Complex of the hospital, were included. Data from the patients, including RAT and RT-PCR for COVID-19, were collected retrospectively. RT-PCR was used as the reference test and compared with RAT. Diagnostic statistics of RAT, with their respective 95% confidence intervals were calculated for RAT in diagnosing COVID-19, with significance at p ≤0.05.

Results: Among the 300 patients, 137 (45.7%) were males and 163 (54.3%) were females. The mean age was 56.80 ± 13.72 years. On screening, 138 (46%) patients tested positive and 162 (54%) were negative by RAT; whereas 213 (71%) tested positive and 87 (29%) were negative on RT-PCR. The sensitivity and specificity of RAT were 54.5% (95% CI: 47.52%-61.28%) and 74.7% (95% CI: 64.25%-83.42%), respectively. Positive predicted value was 84.1% (95% CI: 78.26%-88.53%) and negative predictive value was 40.1% (95% CI: 35.63%-44.79%). The positive likelihood ratio was 2.15 (95% CI: 1.47-3.15). The negative likelihood-ratio was 0.61(95% CI: 0.50-0.74). The overall accuracy was 60.33% (95% CI: 54.55%-65.91%).

Conclusion: There was a low sensitivity and specificity of the RAT for COVID-19, with an overall accuracy of 60.33%, compared with RT-PCR.

Key words: COVID-19, Rapid Antigen Test, Sensitivity, Specificity, RT-PCR.

目的:比较快速抗原试验(RAT)与逆转录聚合酶链反应(RT-PCR)在COVID-19高度疑似患者中的诊断价值,并探讨其诊断参数。研究设计:基于医院的描述性/观察性研究。研究地点和时间:2021年10月至2022年4月,巴基斯坦开伯尔-普赫图赫瓦省白沙瓦医学教学机构/雷丁夫人医院医学系/COVID综合大楼。方法:纳入该医院新冠肺炎综合医院收治的COVID-19高度疑似病例300例,男女不限。回顾性收集患者的数据,包括COVID-19的RAT和RT-PCR。以RT-PCR作为参考检验,并与RAT进行比较。计算RAT诊断COVID-19的诊断统计,并计算其各自的95%置信区间,p≤0.05为显著性。结果:300例患者中,男性137例(45.7%),女性163例(54.3%)。平均年龄56.80±13.72岁。在筛查中,138例(46%)患者检测呈阳性,162例(54%)患者检测呈阴性;而RT-PCR阳性213例(71%),阴性87例(29%)。RAT的敏感性为54.5% (95% CI: 47.52% ~ 61.28%),特异性为74.7% (95% CI: 64.25% ~ 83.42%)。阳性预测值为84.1% (95% CI: 78.26% ~ 88.53%),阴性预测值为40.1% (95% CI: 35.63% ~ 44.79%)。阳性似然比为2.15 (95% CI: 1.47 ~ 3.15)。负似然比为0.61(95% CI: 0.50-0.74)。总体准确率为60.33% (95% CI: 54.55% ~ 65.91%)。结论:与RT-PCR相比,RAT对COVID-19的敏感性和特异性较低,总体准确率为60.33%。关键词:COVID-19,快速抗原检测,敏感性,特异性,RT-PCR
{"title":"Comparison of Rapid Antigen Detection Test with Reverse Transcription Polymerase Chain Reaction in Highly Suspected COVID-19 Patients.","authors":"Muhammad Abdur Rahman Afridi,&nbsp;Zafar Ali,&nbsp;Naveed Iqbal","doi":"10.29271/jcpsp.2023.09.1058","DOIUrl":"https://doi.org/10.29271/jcpsp.2023.09.1058","url":null,"abstract":"<p><strong>Objective: </strong>To compare Rapid Antigen Test (RAT) with Reverse Transcription Polymerase Chain Reaction (RT-PCR) in highly suspected COVID-19 patients and to determine its diagnostic parameters.</p><p><strong>Study design: </strong>Hospital-based, descriptive/observational study. Place and Duration of the Study: Department of Medicine/COVID Complex, Medical Teaching Institution/Lady Reading Hospital, Peshawar, Khyber Pakhtunkhwa, Pakistan, from October 2021 to April 2022.</p><p><strong>Methodology: </strong>A total of 300 highly suspected cases of COVID-19 of either gender admitted in the COVID Complex of the hospital, were included. Data from the patients, including RAT and RT-PCR for COVID-19, were collected retrospectively. RT-PCR was used as the reference test and compared with RAT. Diagnostic statistics of RAT, with their respective 95% confidence intervals were calculated for RAT in diagnosing COVID-19, with significance at p ≤0.05.</p><p><strong>Results: </strong>Among the 300 patients, 137 (45.7%) were males and 163 (54.3%) were females. The mean age was 56.80 ± 13.72 years. On screening, 138 (46%) patients tested positive and 162 (54%) were negative by RAT; whereas 213 (71%) tested positive and 87 (29%) were negative on RT-PCR. The sensitivity and specificity of RAT were 54.5% (95% CI: 47.52%-61.28%) and 74.7% (95% CI: 64.25%-83.42%), respectively. Positive predicted value was 84.1% (95% CI: 78.26%-88.53%) and negative predictive value was 40.1% (95% CI: 35.63%-44.79%). The positive likelihood ratio was 2.15 (95% CI: 1.47-3.15). The negative likelihood-ratio was 0.61(95% CI: 0.50-0.74). The overall accuracy was 60.33% (95% CI: 54.55%-65.91%).</p><p><strong>Conclusion: </strong>There was a low sensitivity and specificity of the RAT for COVID-19, with an overall accuracy of 60.33%, compared with RT-PCR.</p><p><strong>Key words: </strong>COVID-19, Rapid Antigen Test, Sensitivity, Specificity, RT-PCR.</p>","PeriodicalId":54905,"journal":{"name":"Jcpsp-Journal of the College of Physicians and Surgeons Pakistan","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10266779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiological and Genetic Evaluation in Hypotonic Infants. 低血压婴儿的放射学和遗传学评估。
IF 1 4区 医学 Q3 Medicine Pub Date : 2023-09-01 DOI: 10.29271/jcpsp.2023.09.1028
Selen Gur, Gurkan Gurbuz, Hilmi Tozkir

Objective: To investigate the importance and diagnostic yield of genetic and radiological evaluations in children with hypotonia.

Study design: Comparative observational study. Place and Duration of the Study: Department of Pediatrics Neurology, Namik Kemal University, Tekirdag, Turkey, between 2019 and 2022.

Methodology: Patients' medical histories, laboratory results, radiological examinations, and genetic tests, if any, were obtained retrospectively from the patients' clinic files. Children with hypotonia detected since the infantile period and who were on regular follow-up were included in the study. Patients who lost the follow-up were excluded.

Results: Out of one hundred and seventy patients, 61.8% (n=105) were boys and 38.2% (n=65) were girls. The admission age of the patients ranged from 1 to 121 months; the mean age at presentation was 13.52±17.35 months. Hypotonia was central in 85.3% (n=145), peripheral in 12.4% (n=21), and mixed in 2.3% (n=4). Cerebral palsy was the predominant, non-genetic clinical cause of hypotonia (n=66, 39%). Brain magnetic resonance imaging (MRI) was normal in 48.2% (n=82). The most common MRI abnormality was periventricular leukomalacia in 15.9% (n=27). Sixty-five (38.2%) patients were diagnosed genetically. More than half of the patients with a genetic diagnosis were diagnosed by whole exome sequencing (WES).

Conclusion: Brain MRI is the first choice for the patients with central hypotonia. Patients who cannot be diagnosed with clinical findings and brain MRI should undergo WES. This is helpful for the long-term prognosis and management.

Key words: Hypotonia, Whole exome sequencing, Magnetic resonance, Spinal muscular atrophy, Cerebral palsy.

目的:探讨遗传和放射学评估在儿童肌张力减退中的重要性和诊断价值。研究设计:比较观察研究。研究地点和持续时间:2019年至2022年间,土耳其特基尔达格纳米克凯末尔大学儿科神经病学系。方法:从患者的临床档案中回顾性获得患者的病史、实验室结果、放射学检查和基因测试(如有)。从婴儿期开始检测到肌张力低下并定期随访的儿童被纳入研究。失去随访的患者被排除在外。结果:在一百七十名患者中,男孩占61.8%(n=105),女孩占38.2%(n=65)。患者入院年龄为1~121个月;平均年龄13.52±17.35个月。中枢性低血压85.3%(n=145),外周性低血压12.4%(n=21),混合性低血压2.3%(n=4)。脑瘫是引起肌张力减退的主要非遗传临床原因(n=66,39%)。脑磁共振成像(MRI)正常者占48.2%(n=82)。最常见的MRI异常是室周白质软化,占15.9%(n=27)。65名(38.2%)患者经基因诊断。超过一半的基因诊断患者是通过全外显子组测序(WES)诊断的。结论:脑MRI是治疗中枢性肌张力减退的首选方法。不能通过临床表现和脑部MRI进行诊断的患者应进行WES。这有助于长期预后和管理。关键词:低血压,全外显子组测序,磁共振,脊髓性肌萎缩,脑瘫。
{"title":"Radiological and Genetic Evaluation in Hypotonic Infants.","authors":"Selen Gur,&nbsp;Gurkan Gurbuz,&nbsp;Hilmi Tozkir","doi":"10.29271/jcpsp.2023.09.1028","DOIUrl":"10.29271/jcpsp.2023.09.1028","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the importance and diagnostic yield of genetic and radiological evaluations in children with hypotonia.</p><p><strong>Study design: </strong>Comparative observational study. Place and Duration of the Study: Department of Pediatrics Neurology, Namik Kemal University, Tekirdag, Turkey, between 2019 and 2022.</p><p><strong>Methodology: </strong>Patients' medical histories, laboratory results, radiological examinations, and genetic tests, if any, were obtained retrospectively from the patients' clinic files. Children with hypotonia detected since the infantile period and who were on regular follow-up were included in the study. Patients who lost the follow-up were excluded.</p><p><strong>Results: </strong>Out of one hundred and seventy patients, 61.8% (n=105) were boys and 38.2% (n=65) were girls. The admission age of the patients ranged from 1 to 121 months; the mean age at presentation was 13.52±17.35 months. Hypotonia was central in 85.3% (n=145), peripheral in 12.4% (n=21), and mixed in 2.3% (n=4). Cerebral palsy was the predominant, non-genetic clinical cause of hypotonia (n=66, 39%). Brain magnetic resonance imaging (MRI) was normal in 48.2% (n=82). The most common MRI abnormality was periventricular leukomalacia in 15.9% (n=27). Sixty-five (38.2%) patients were diagnosed genetically. More than half of the patients with a genetic diagnosis were diagnosed by whole exome sequencing (WES).</p><p><strong>Conclusion: </strong>Brain MRI is the first choice for the patients with central hypotonia. Patients who cannot be diagnosed with clinical findings and brain MRI should undergo WES. This is helpful for the long-term prognosis and management.</p><p><strong>Key words: </strong>Hypotonia, Whole exome sequencing, Magnetic resonance, Spinal muscular atrophy, Cerebral palsy.</p>","PeriodicalId":54905,"journal":{"name":"Jcpsp-Journal of the College of Physicians and Surgeons Pakistan","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10563476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Jcpsp-Journal of the College of Physicians and Surgeons Pakistan
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1